1. Home
  2. BIO vs PIPR Comparison

BIO vs PIPR Comparison

Compare BIO & PIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$262.97

Market Cap

7.1B

Sector

Industrials

ML Signal

HOLD

Logo Piper Sandler Companies

PIPR

Piper Sandler Companies

HOLD

Current Price

$293.85

Market Cap

5.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIO
PIPR
Founded
1952
1895
Country
United States
United States
Employees
7450
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Investment Bankers/Brokers/Service
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
5.8B
IPO Year
N/A
2003

Fundamental Metrics

Financial Performance
Metric
BIO
PIPR
Price
$262.97
$293.85
Analyst Decision
Strong Buy
Buy
Analyst Count
4
3
Target Price
$358.50
$365.50
AVG Volume (30 Days)
235.7K
175.1K
Earning Date
04-30-2026
05-01-2026
Dividend Yield
N/A
2.64%
EPS Growth
N/A
54.49
EPS
N/A
15.82
Revenue
N/A
$1,904,217,000.00
Revenue This Year
$2.74
$13.14
Revenue Next Year
$3.05
$13.08
P/E Ratio
$9.72
$18.62
Revenue Growth
N/A
24.33
52 Week Low
$211.43
$202.91
52 Week High
$343.12
$380.26

Technical Indicators

Market Signals
Indicator
BIO
PIPR
Relative Strength Index (RSI) 40.24 42.30
Support Level $239.33 $276.37
Resistance Level $289.61 $341.25
Average True Range (ATR) 7.46 8.68
MACD 0.44 2.13
Stochastic Oscillator 19.99 57.50

Price Performance

Historical Comparison
BIO
PIPR

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About PIPR Piper Sandler Companies

Piper Sandler Cos is an investment bank and institutional securities firm, serving the needs of corporations, private equity groups, public entities, non-profit entities and institutional investors in the United States (U.S.) and internationally. The company provides a broad set of products and services, including financial advisory services; equity and debt capital markets products; public finance services; institutional brokerage services; fundamental equity and macro research services; fixed income services; and alternative asset management strategies. It generates maximum revenue from Advisory services followed by Equity financing.

Share on Social Networks: